Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 13 of the 34 sources its claims cite were checked for support.

Cellular senescence: at the nexus between ageing and diabetes

Open access

Abstract

Ageing and diabetes lead to similar organ dysfunction that is driven by parallel molecular mechanisms, one of which is cellular senescence. The abundance of senescent cells in various tissues increases with age, obesity and diabetes. Senescent cells have been directly implicated in the generation of insulin resistance. Recently, drugs that preferentially target senescent cells, known as senolytics, have been described and recently entered clinical trials. In this review, we explore the biological links between ageing and diabetes, specifically focusing on cellular senescence. We summarise the current data on cellular senescence in key target tissues associated with the development and clinical phenotypes of type 2 diabetes and discuss the therapeutic potential of targeting cellular senescence in diabetes.

Overview

CoChat Summary

TL;DR

Cellular senescence is a fundamental ageing mechanism that is increased with age, obesity and diabetes and is directly implicated in insulin resistance and diabetic complications. Senolytic drugs that selectively clear senescent cells improve metabolic and organ dysfunction in animal models and have entered early human trials, making senescence a promising therapeutic target in diabetes.

Key findings

  • Senescent cell abundance increases with ageing, obesity and diabetes, and polymorphisms in senescence markers such as CDKN2A are associated with increased risk of type 2 diabetes and cardiovascular disease.
  • In adipose tissue, senescent progenitor cells inhibit adipogenesis and secrete SASP factors such as activin A, IL-6 and TNF-α, directly contributing to insulin resistance; p53 activation in adipose tissue also blunts insulin-induced glucose transport and increases lipolysis.
  • In mice, reducing senescent cell burden genetically or with senolytics (e.g. dasatinib plus quercetin, D+Q) improves glucose tolerance, insulin sensitivity, microalbuminuria and diastolic heart dysfunction; senolytic treatment also alleviated proteinuria in obese insulin-resistant mice and steatosis in fatty liver models.
  • The first clinical trial of senolytics reported improved physical function in patients with idiopathic pulmonary fibrosis after 3 weeks of intermittent D+Q treatment, though larger randomised controlled trials are needed.

Methods

  • Narrative review exploring biological links between ageing and diabetes, with a focus on cellular senescence.
  • Synthesises evidence from human studies and genetically modified, diet-induced and ageing animal models across tissues including adipose tissue, beta cells, liver, cardiovascular system, kidney and brain.
  • No systematic search strategy, inclusion criteria or meta-analysis is described; the paper is a conceptual and literature-based synthesis.

Limitations

  • The paper states gaps in knowledge for clinical translation: need to determine trial length, identify reliable or universal senescence biomarkers, elucidate kinetics of senescent cell formation and reappearance under ongoing insults such as nutrient excess, and assess senolytic efficacy in early vs late disease.
  • Evident from the text: many mechanistic findings come from animal models, and the authors note that the role of cellular senescence in diabetic microvascular complications involving eyes, nerves and kidneys is not well defined.
  • Evident from the text: as a narrative review, it does not report a systematic evidence appraisal or quantitative synthesis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00125-019-4934-x

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Conditions associated with both advanced age and diabetes. This figure is available as part of a downloadable slideset
Fig. 1 Conditions associated with both advanced age and diabetes. This figure is available as part of a downloadable slidesetCC BY · PubMed Central
Fig. 2 Consequences of fundamental ageing processes. ICU, intensive care unit; MCI, mild cognitive impairment. This figure is available as part of a downloadable slideset
Fig. 2 Consequences of fundamental ageing processes. ICU, intensive care unit; MCI, mild cognitive impairment. This figure is available as part of a downloadable slidesetCC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 0 Not valid · 11 Not checked · 9 Own results and interpretations

8 more claims · 3 with their cited sources checked

Create a free account to see all 30 claims and to verify the 21 references still open.

See all claims — free account
  • It may state two separate claims as one. 15
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Cited by

See all 339

Metadata

Authors
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U.
Affiliations
  • Mayo Clinic (US)
  • Sahlgrenska University Hospital (SE)
Corresponding author
  • Kirkland, James L.
  • Smith, Ulf
Venue
Diabetologia
Published
2019-08-27
Volume
62
Issue
10
Pages
1835-1841
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2971121994
Cited by
337
References
54
Citations by year
2026: 43 · 2025: 59 · 2024: 66 · 2023: 49 · 2022: 49 · 2021: 37 · 2020: 32 · 2019: 2
FWCI
3.52
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
University of Gothenburg
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, aging, type 2 diabetes, insulin resistance, senolytics, obesity, senescent cells, organ dysfunction
MeSH terms
Aging, Animals, Diabetes Mellitus, Type 2, Humans, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cellular senescence: at the nexus between ageing and diabetes. https://app.cochat.ai/papers/10.1007/s00125-019-4934-x
The paper
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U. (2019). Cellular senescence: at the nexus between ageing and diabetes. Diabetologia. https://doi.org/10.1007/s00125-019-4934-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.